145 related articles for article (PubMed ID: 36103974)
41. Thiazolidinediones cause compaction of nuclear heterochromatin in the pluripotent mesenchymal cell line C3H10T1/2 when inducing an adipogenic phenotype.
Chappard D; Marchand-Libouban H; Moreau MF; Baslé MF
Anal Quant Cytopathol Histpathol; 2013 Apr; 35(2):85-94. PubMed ID: 23700717
[TBL] [Abstract][Full Text] [Related]
42. High-Fat Diet-Induced Obesity Promotes Expansion of Bone Marrow Adipose Tissue and Impairs Skeletal Stem Cell Functions in Mice.
Tencerova M; Figeac F; Ditzel N; Taipaleenmäki H; Nielsen TK; Kassem M
J Bone Miner Res; 2018 Jun; 33(6):1154-1165. PubMed ID: 29444341
[TBL] [Abstract][Full Text] [Related]
43. A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone.
Bruedigam C; Eijken M; Koedam M; van de Peppel J; Drabek K; Chiba H; van Leeuwen JP
Stem Cells; 2010 May; 28(5):916-27. PubMed ID: 20213769
[TBL] [Abstract][Full Text] [Related]
44. Peroxisome Proliferator-activated Receptor-γ Activation Augments the β-Cell Unfolded Protein Response and Rescues Early Glycemic Deterioration and β Cell Death in Non-obese Diabetic Mice.
Maganti AV; Tersey SA; Syed F; Nelson JB; Colvin SC; Maier B; Mirmira RG
J Biol Chem; 2016 Oct; 291(43):22524-22533. PubMed ID: 27613867
[TBL] [Abstract][Full Text] [Related]
45. The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice.
Shimaya A; Kurosaki E; Nakano R; Hirayama R; Shibasaki M; Shikama H
Metabolism; 2000 Mar; 49(3):411-7. PubMed ID: 10726922
[TBL] [Abstract][Full Text] [Related]
46. Effects of DSP-8658, a novel selective peroxisome proliferator-activated receptors a/γ modulator, on adipogenesis and glucose metabolism in diabetic obese mice.
Goto T; Nakayama R; Yamanaka M; Takata M; Takazawa T; Watanabe K; Maruta K; Nagata R; Nagamine J; Tsuchida A; Kato H
Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):492-9. PubMed ID: 26011171
[TBL] [Abstract][Full Text] [Related]
47. Suppressive effect of pioglitazone, a PPAR gamma ligand, on azoxymethane-induced colon aberrant crypt foci in KK-Ay mice.
Ueno T; Teraoka N; Takasu S; Nakano K; Takahashi M; Yamamoto M; Fujii G; Komiya M; Yanaka A; Wakabayashi K; Mutoh M
Asian Pac J Cancer Prev; 2012; 13(8):4067-73. PubMed ID: 23098518
[TBL] [Abstract][Full Text] [Related]
48. Protein malnutrition induces bone marrow mesenchymal stem cells commitment to adipogenic differentiation leading to hematopoietic failure.
Cunha MC; Lima Fda S; Vinolo MA; Hastreiter A; Curi R; Borelli P; Fock RA
PLoS One; 2013; 8(3):e58872. PubMed ID: 23516566
[TBL] [Abstract][Full Text] [Related]
49. Differential effects of PPAR-{gamma} activation versus chemical or genetic reduction of DPP-4 activity on bone quality in mice.
Kyle KA; Willett TL; Baggio LL; Drucker DJ; Grynpas MD
Endocrinology; 2011 Feb; 152(2):457-67. PubMed ID: 21177828
[TBL] [Abstract][Full Text] [Related]
50. Identification of a mitochondrial target of thiazolidinedione insulin sensitizers (mTOT)--relationship to newly identified mitochondrial pyruvate carrier proteins.
Colca JR; McDonald WG; Cavey GS; Cole SL; Holewa DD; Brightwell-Conrad AS; Wolfe CL; Wheeler JS; Coulter KR; Kilkuskie PM; Gracheva E; Korshunova Y; Trusgnich M; Karr R; Wiley SE; Divakaruni AS; Murphy AN; Vigueira PA; Finck BN; Kletzien RF
PLoS One; 2013; 8(5):e61551. PubMed ID: 23690925
[TBL] [Abstract][Full Text] [Related]
51. Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone).
Sottile V; Seuwen K; Kneissel M
Calcif Tissue Int; 2004 Oct; 75(4):329-37. PubMed ID: 15549648
[TBL] [Abstract][Full Text] [Related]
52. Improved insulin sensitivity after treatment with PPARγ and PPARα ligands is mediated by genetically modulated transcripts.
Rasouli N; Kern PA; Elbein SC; Sharma NK; Das SK
Pharmacogenet Genomics; 2012 Jul; 22(7):484-97. PubMed ID: 22437669
[TBL] [Abstract][Full Text] [Related]
53. Activation of the PDGFRα-Nrf2 pathway mediates impaired adipocyte differentiation in bone marrow mesenchymal stem cells lacking Nck1.
Haider N; Larose L
Cell Commun Signal; 2020 Feb; 18(1):26. PubMed ID: 32059739
[TBL] [Abstract][Full Text] [Related]
54. Effects of pioglitazone on insulin sensitivity and serum lipids in obese cats.
Clark M; Thomaseth K; Dirikolu L; Ferguson DC; Hoenig M
J Vet Intern Med; 2014; 28(1):166-74. PubMed ID: 24592408
[TBL] [Abstract][Full Text] [Related]
55. Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis.
Lecka-Czernik B
Curr Osteoporos Rep; 2010 Dec; 8(4):178-84. PubMed ID: 20809203
[TBL] [Abstract][Full Text] [Related]
56. Pioglitazone attenuates fatty acid-induced oxidative stress and apoptosis in pancreatic beta-cells.
Saitoh Y; Chun-ping C; Noma K; Ueno H; Mizuta M; Nakazato M
Diabetes Obes Metab; 2008 Jul; 10(7):564-73. PubMed ID: 17593232
[TBL] [Abstract][Full Text] [Related]
57. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
[TBL] [Abstract][Full Text] [Related]
58. Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets.
Fellous T; De Maio F; Kalkan H; Carannante B; Boccella S; Petrosino S; Maione S; Di Marzo V; Iannotti FA
Biochem Pharmacol; 2020 May; 175():113859. PubMed ID: 32061773
[TBL] [Abstract][Full Text] [Related]
59. Obesity modifies bone marrow microenvironment and directs bone marrow mesenchymal cells to adipogenesis.
da Silva SV; Renovato-Martins M; Ribeiro-Pereira C; Citelli M; Barja-Fidalgo C
Obesity (Silver Spring); 2016 Dec; 24(12):2522-2532. PubMed ID: 27753270
[TBL] [Abstract][Full Text] [Related]
60. Pioglitazone improves insulin secretory capacity and prevents the loss of beta-cell mass in obese diabetic db/db mice: Possible protection of beta cells from oxidative stress.
Ishida H; Takizawa M; Ozawa S; Nakamichi Y; Yamaguchi S; Katsuta H; Tanaka T; Maruyama M; Katahira H; Yoshimoto K; Itagaki E; Nagamatsu S
Metabolism; 2004 Apr; 53(4):488-94. PubMed ID: 15045697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
